Dr. Ashay Karpe has over 15 years of experience in clinical hematology and oncology. He completed his DM in Medical Oncology in 2015 from Tata Memorial Hospital in Mumbai where he received a gold medal. His areas of specialty include hematological malignancies, stem cell transplants, and solid tumors. He has published several papers in clinical research and presented posters at oncology conferences. He is currently working as an oncologist at Tata Memorial Hospital and has strong references from leaders in the fields of hematology and oncology.

1. Curriculum Vitae
DR. ASHAY PRAMOD KARPE
Date ofBirth- 31/08/1979
Address- 7/11,Arihant CHS, Kastur Park,Shimpoli Road, Borivali (West), Mumbai -400092
Contact No-+ 91-9969329294/9029083054
Email ID- ashayoncology@gmail.com, drashayk@rediffmail.com
EDUCATIONAL QUALIFICATIONS:-
M.B.B.S., M.D.(Gen Med),D.M. (Medical Oncology) , D.N.B. (Medical Oncology)
CLINICAL EXPERIENCE:-
D.M. (Medical Oncology) - - Sept 2012 till Date
- Tata Memorial Hospital, Mumbai
- Passed in June 2015
* Gold medal in Final Exams
- Trained in managing Solid Tumors, Haematological
Malignancies and Stem Cell Transplant
- Completion of tenure- 31/07/2016
FellowClinical Haematology- - May 2011- July 2012
-Tata Medical Center, Kolkata
-Trained in Benign & Malignant Haematology, Stem
Cell Transplant

2. Sp. Registrar (Clinical Haematology) - June 2007- Nov 2010
-Sahyadri Speciality Hospital, Pune
-Trained in Clinical & Laboratory Haematology – Both
benign & malignant
- Mainly focused on Stem Cell Transplant (Autologous,
Allogeneic, Haploidentical, Matched Unrelated Donor,
Cord blood Transplants)
- Trained in Clinical Research (Co-principal
Investigator in Various Clinical Trials)
M.D. (Gen Med)- -Jan 2004-March 2007
-Govt. Medical College & Hospital, Aurangabad
*Gold Medal in Final Exams – March 2007
Clinical Registrar - - March 2002 - Sept 2002, March 2003- Jan 2004
- Suvarna Hospital, Borivali (West),Mumbai
M.B.B.S .- -Sept 1996- Jan 2002
-Seth G.S. Medical College, K.E.M. Hosp,Mumb
AREAS OF SPECIAL INTEREST :-
Haematological malignancies, Stem Cell Transplant
Solid Tumors- Breast and Gynecological malignancies, Lung Cancer,Testicular Cancers

3. CLINICAL RESEARCH AND PUBLICATIONS-
1. Technically unresectable recurrent oral cancers: Is NACTthe answer? - Vijay M. Patil, Amit
Joshi, Vanita Noronha, Ashay Karpe,Anant Ramaswamy,Sachin Dhumal, Shashikant Juvekar,
Supreeta Arya, Abhishek Mahajan, Pankaj Chaturvedi, Prathamesh Pai, Anil D’Cruz, Kumar
Prabhash. Oral Oncology -May 2016 May;56:e12-4.doi: 10.1016 j.oraloncology.2016.03.015.
Epub 2016 Mar 31.
2. Metronomic palliative chemotherapy in maxillary sinus tumor :- Vijay M Patil, Vanita Noronha,
Amit Joshi, Ashay Karpe,Vikas Talreja, Arun Chandrasekharan,Sachin Dhumal, Kumar Prabhash,
South Asian Journal ofCancer-2016 (Vol 5) Issue 2;P- 56-58
3. Rare Congenital Bleeding Disorders from a Tertiary Haematology Referral Center in Western
India. Anjali Jaydeep Kelkar, Shashikant Apte, Varsha Melinkeri, Samir Melinkeri, Ashay Karpe,
Saurabh Bhave, and Bhavna Sayaji. Blood (ASH Annual Meeting Abstracts),Nov 2008; 112:
4519
4. Oral TKI in Poor PS Lung Cancer Patients : P131-F004 S.Jandyal, A.Karpe,V.Patil, V.Noronha,
A.Joshi, A.Bhattacharjee,K.Prabhash. European Journal ofCancer 54,Suppl.1(2016)S29
5. Efficacy of second line Erlotinib in patients post progression offirst line therapy in Head and
Neck cancers: P227-D019. V.Patil, A.Joshi,A.Karpe,V.Noronha, V.Muddu, A.Bhattacharjee,
S.Dhumal, K.Prabhash. European Journal ofCancer 54,Suppl.1(2016)S24
6. Efficacy of second-line erlotinib in patients postprogression offirst-line chemotherapy in head
and neck cancers :-V Patil, A Karpe,V Noronha, A Joshi, V Muddu, A Bhattacharjee,S Dhumal,
K Prabhash. Indian Journal of Cancer-2015 (52)-Issue4;P-629-631

4. POSTER PRESENTATIONS-
1. Epidermal Growth Factor Receptor Mutation in Small Cell Lung Cancer Patients in Tertiary
Care Oncology Hospital: Incidence and Clinical Outcome- A.Karpe,V.Noronha,A.Chougule,
A.Joshi, R.Kumar,V.M.Patil, K.Prabhash. Asian Clinical Oncology Society (ACOS) 2016 held in
Delhi.
2. A rare case ofCML with minor breakpoint: Dr.Saurabh Bhave, Dr.Ashay Karpe,Dr.Shashikant
Apte, Dr.Sameer Melinkeri, Dr.Varsha Melinkeri, Dr.Bhavna Sayaji, Dr.Anjali Kelkar. Poster paper
presentation in National Haematology Conference Pudduchery 2008. Best paperin posters session.
3. Association ofalpha Thalassemia with sickle cell disease: Dr.Ashay Karpe,Dr.Saurabh Bhave,
Dr.Shashikant Apte, Dr.Sameer Melinkeri, Dr.Varsha Melinkeri, Dr.Bhavna Sayaji, Dr.Anjali Kelkar
Poster paper presentation in National Haematology Conference Pudduchery 2008.
4. Rare combination ofCodon15(-T) mutation ofbeta globin gene and HPFH resulting
inThalassemia intermedia phenotype : Dr.AnjaliKelkar, Mrs.Anu Moses,Mrs.Pallavi Date, Dr.Ashay
Karpe,Dr.Shashikant Apte, Dr.Varsha Melinkeri A case report : Poster paper presentation National
Haematology conference at Kolkata 2010

5. REFERENCES:-
1. Dr. Sameer Melinkeri. D.M.(Clinical Haematolgy)
Clinical Haematologist and Stem Cell Transplant Physician
Deenanath Mangeshkar Hospital,Pune
Sahyadri Speciality Hospital, Pune
Contact- 91-9766249644/ 9673338140
Email ID- docmelinkeri@yahoo.com
2. Prof (Dr.) Navin Khattry. D.M. (Med Onco)
Clinical Haematologist and Head of Stem Cell Transplant Unit
Contact – 91-9869451619/ 9892501884
Email ID- nkhattry@gmail.com
ACTREC (Tata Hospital,Kharghar-Navi Mumbai) and Tata Memorial Hospital,Mumbai
3. Prof (Dr.) Kumar Prabhash. D.M. (Med Onco)
Head of Unit 2 Solid Tumor
Tata Memorial Hospital,Parel, Mumbai
Contact- 91-9167760576
Email ID- kprabhash1@gmail.com
4. Prof (Dr.) S.D.Banavali.MD
Head of Department- Pediatric and Adult Medical Oncology
Tata Memorial Hospital, Parel, Mumbai
Contact- 91-9820074514
Email ID- banavali_2000@yahoo.com